Dec 18 (Reuters) - Hologic Inc HOLX.O:
FDA: HOLOGIC REMOVES BIOZORB 3D BIOABSORBABLE MARKERS DUE TO RISK FOR PATIENT COMPLICATIONS
FDA: THERE HAVE BEEN 252 REPORTED INJURIES RELATED TO HOLOGIC'S BIOZORB 3D BIOABSORBABLE MARKERS
FDA: IDENTIFIED HOLOGIC'S RECALL AS MOST SERIOUS TYPE; RECALL INVOLVES REMOVING DEVICES FROM WHERE THEY ARE USED/SOLD
Source text: [ID:]
Further company coverage: HOLX.O
((Reuters.Briefs@thomsonreuters.com;))